203-481-7 | Sigma-Aldrich

Quality Control Range Sheet- HCY-116 and HCY-216

pg/mL IL-6 Control 1 98 – 203 pg/mL *RANTES Control 1 99 – 205 pg/mL Control 2 478 – 994 pg/mL Control 2 517 –

Quality Control Range Sheet- HCKP2-103 and HCKP2-203

Nectin-2 Control 1 413 - 857 pg/ml Control 2 1245 - 2585 pg/ml BAFF Control 1 232 - 481 pg/ml Control 2 658 - 1366 pg/ml

Quality Control Range Sheet- A6602-106 and A6602-206

100 – 207 pg/mL IL-1RA Control 1 48 – 100 pg/mL Control 2 494 – 1026 pg/mL Control 2 232 – 481 pg/mL

XP725 Antibody Number-Lot Number 071M4826

450 451 452 473 474 475 476 5.6 405 406 407 408 429 430 431 432 453 454 455 456 477 478 479 480 6.1 481 482 483 484 505 506 507 508 529 530 531 532 553 554 555 556 6.2 485

Product Information Sheet - ROAMYC

TABELLENREIHE> Triton X-100 Triton X-100 5 × 10 ml 5 × 10 ml 11 332 481 001 11 332 481 001 Tween

Article: Evaluation of immunological parameters in pit bull terrier-type dogs with juvenile onset generalized demodicosis and age-matched healthy pit bull terrier-type dogs

Zajac AJ. T-cell exhaustion: characteristics, causes and conversion. Immunology 2010; 129: 474–481. 10. Kumari P, Nigam R, Singh A et al. Demodex canis regulates cholinergic system mediated immunosuppressive

XP725 Antibody List Lot 129K4831

722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d 206 Cytokeratin

XP725 Antibody List Lot 129K4830

722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d 206 Cytokeratin

MAPK: Antibodies, Proteins, Kits, siRNA and Reagents

lane 2) MCF-7 cells were probed with Anti-phospho-Erb B2/HER-2 (Tyr1248) (1:2000 dilution). 17 Anti-phospho-MAP Kinase1/2 (Erk 1/2) 12D4 Av H M R IP WB Pur M IgG1κ 50 µg 05-481

XP725 Antibody List Lot 089K4791

722 Transportin 1 T0825 3842 TNPO1 M NP_002261.3 y y y 203 Cytokeratin peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d 206 Cytokeratin

Advanced Applications of Engineered Nanomaterials

�001, 31, 203. (5) Cho, S.J., Jarrett, B.R., Louie, A.Y., Kauzlarich, S.M., Nanotechnology, �00�, 17, 640. (6) Niemeyer, C.M., Angewandte Chemie, International Edition, �001, 40, 4128. (7) Mornet, S

List of Antibodies

M y n/d n/d 202 Cytohesin-1 C8979 M y n/d n/d 203 Cytokeratin peptide 4 C5176 M y n/d n/d 204 Cytokeratin CK5 C7785 M y n/d n/d 205 Cytokeratin peptide 7 C6417 M y n/d n/d 206 Cytokeratin 8.12 C7034 M

Cytoskeletal Signaling Antibodies, Reagents and Kits

IgG2a 200 µg 05-157 Anti-phospho-MAP Kinase1/2 (Erk 1/2) 12D4 Av H M R IP WB Pur M IgG1κ 50 µg 05-481 Anti-phospho-MAP Kinase 1/2 AW39 H R BD WB Pur Rb IgG 100 µL 05-797 (Erk1/2)(Thr185/Tyr187)

XP725 Antibody List

NP_059430.2 M y n/d n/d 203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d 204 Cytokeratin CK5 C7785 3875 KRT18 NP_954657.1 M y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 NP_005547.3

XP725 Antibody List 013M4793

NP_059430.2 M y n/d n/d 203 Cytokeratin peptide 4 C5176 3851 KRT4 NP_002263.2 M y n/d n/d 204 Cytokeratin CK5 C7785 3875 KRT18 NP_954657.1 M y n/d n/d 205 Cytokeratin peptide 7 C6417 3855 KRT7 NP_005547.3

Halal Certificate

FORMATE W335304 C42596 HC-23SI9P20 480. CIS-3-HEXENYL HEXANOATE 98%, FG W340308 A99561 HC-23SIM918 481. CIS-3-HEXENYL ISOBUTYRATE 98%, FG W392901 A91511 HC-23SI5F62 482. CIS-3-HEXENYL LACTATE 98%, FG

Halal Certificate

FORMATE W335304 C42596 HC-22SICY41 480. CIS-3-HEXENYL HEXANOATE 98%, FG W340308 A99561 HC-22SI2739 481. CIS-3-HEXENYL ISOBUTYRATE 98%, FG W392901 A91511 HC-22SIZX83 482. CIS-3-HEXENYL LACTATE 98%, FG